Service Hotline +86 400-068-7188
Service Hotline +86 400-068-7188
China Anti-tumor Drug Industry Market Prospects and Investment Strategy Planning Report, 2013-2017
A must-have for enterprise medium to long-term strategic planning
Without deep industry knowledge, it will be difficult to gain any return
English Version：USD7900
Including: Paper back + Electronic Copy + Invoice
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188After-sales Hotline： +86 755-33013088
The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188
0755 - 82925195
400-068-7188
We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product.
Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase.
Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the"
"trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!
* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!
Table of Contents
Content Summary
Chapter 1: Development Overview of Anti-tumor Drug Industry
1.1 Research Background and Methods for Report
1.1.1 Introduction of Research Departments for Report
1.1.2 Research Background of Report
1.1.3 Overview of Research Methods
(1) Statistic Standards for Data
(2) Concept of Research Methods
1.2 Overview of Anti-tumor Drug Industry
1.2.1 Concept and Classification of Tumor
(1) Concept of Tumor
(2) Classification of Tumor
1.2.2 Classification of Antineoplastic Drugs
1.3 Policy Environment for Antineoplastic Drugs
1.3.1 Supervision System for Antineoplastic Drugs
1.3.2 Policies Related to Anti-tumor Drug Industry
(1) Policies and Regulations Related to Anti-tumor Drug Industry
(2) Explanation of Policies Related to the Industry
1.3.3 Impact of New Reform on the Industry
1.3.4 Policy Forecast for Anti-tumor Drug Industry
1.4 Financial Conditions of Anti-tumor Drug Industry
1.4.1 Growth of Domestic GDP Growth
1.4.2 Income of Residential Income
1.4.3 Residential Consumption Level
1.4.4 Residential Medical Care
1.4.5 Development Forecast for Macro-economy
1.5 Social Environment for Anti-tumor Drug Industry
1.5.1 Population Growth and Aging Trend
1.5.2 Tumor Disease and Environmental Pollution
1.6 Technical Environment for Anti-tumor Drug Industry
1.6.1 Technical Environment Status
1.6.2 Patent Technology of Anti-tumor Drug Industry
Chapter 2: Analysis of Development Situation of Anti-tumor Drug Industry
2.1 Development Overview of International Anti-tumor Drug Industry
2.1.1 Development Size of International Anti-tumor Drug Industry
2.1.2 Competitive Landscape of International Anti-tumor Drug Industry
2.1.3 Development Trend for International Anti-tumor Drug Industry
2.2 Development Status of Domestic Anti-tumor Drug Industry
2.2.1 Development History of Anti-tumor Drug Industry
2.2.2 Development Size of Anti-tumor Drug Industry
2.2.3 Development Trend for Anti-tumor Drug Industry
2.3 Competitive Landscape of Anti-tumor Drug Industry
2.3.1 Market Pattern of Anti-tumor Drug Industry
2.3.2 Proportion of Product in Anti-tumor Drug Industry
2.3.3 Core Competitive Factors of Anti-tumor Drug Industry
2.3.4 Potential Entrants of Anti-tumor Drug Industry
Chapter 3: Analysis of Product Market of Anti-tumor Drug Industry
3.1 Analysis of Chemical Antineoplastic Drugs Market
3.1.1 Analysis of Natural Antineoplastic Drugs Market
(1) Docetaxel Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(2) Taxol Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(3) Topotecan Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
3.1.2 Analysis of Antimetabolite Market
(1) Capecitabine Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(2) Gemcitabine Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(3) Pemetrexed Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
3.1.3 Analysis of Antitumor Antibiotics Market
(1) Epirubicin Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(2) Pirarubicin Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
3.1.4 Analysis of An-tumor Hormone Market
(1) Letrozole Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(2) Anastrozole Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(3) Flutamide Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(4) Decapeptyl Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(5) Goserelin Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(6) Leuprorelin Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
3.1.5 Analysis of Alkylating Agent Market
(1) Temozolomide Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(2) Ifosfamide Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
3.1.6 Analysis of Other Product Market
(1) Oxaliplatin Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(2) Gefitinib Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(3) G-CSF Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(4) Lentinan Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(5) Recombinant Human IL Market
1) Drug Size of Sample Hospital
2) Pattern of Manufacture
(6) Erlotinib Market
(7) Imatinib Market
(8) Sorafenib Market
(9) Sunitinib Market
(10) Rituximab
(11) Trastuzumab
(12) Cetuximab
(13) Nimotuzumab
3.2 Analysis of Traditional Chinese Medicine Anti-Tumor Market
3.2.1 Analysis of Kang'ai Injection Market
(1) Drug Size of Sample Hospital
(2) Pattern of Manufacture
3.2.2 Shenqifuzheng Injection
(1) Drug Size of Sample Hospital
(2) Pattern of Manufacture
3.2.3 Lentinan Injection
(1) Drug Size of Sample Hospital
(2) Pattern of Manufacture
3.2.4 Compound Kushen Injection
(1) Drug Size of Sample Hospital
(2) Pattern of Manufacture
3.2.5 Analysis of Jinshuibao Capsule Market
(1) Drug Size of Sample Hospital
(2) Pattern of Manufacture
3.2.6 Corporate Pattern of Aidi Injection
(1) Drug Size of Sample Hospital
(2) Pattern of Manufacture
3.2.7 Brucea Javanica Oil Emulsion
(1) Drug Size of Sample Hospital
(2) Pattern of Manufacture
3.2.8 Analysis of Other Products Market
(1) Ankangxin Capsule Market
(2) Kanglaite Injection Market
(3) Huaier Granule Market
(4) Anti-cancer Injection Market
(5) Compound Cantharis Capsule
Chapter 4: Analysis of Supply and Demand for Tumor Medical Service Market
4.1 Prevalence Rate Research on Resident’s Tumor Disease
4.1.1 Overall Prevalence Rate of Resident’s Tumor Disease
4.1.2 Prevalence Rate of Urban Resident’s Tumor Disease
4.1.3 Prevalence Rate of Rural Resident’s Tumor Disease
4.2 Research on Consultation Rate for Residents Suffering from Tumor Disease
4.2.1 Consultation Rate for Residents Suffering from Tumor Disease
(1) Overall Consultation Rate for Residents Suffering from Tumor Disease
(2) Consultation Rate for Urban Residents Suffering from Tumor Disease
(3) Consultation Rate for Rural Residents Suffering from Tumor Disease
4.2.2 Hospitalization Rate of Residents Suffering from Tumor Disease
(1) Overall Hospitalization Rate of Residents Suffering from Tumor Disease
(2) Hospitalization Rate of Urban Residents Suffering from Tumor Disease
4.2.3 Health Treatment-seeking of Residents Suffering from Tumor Disease
(1) Prognosis of Disease for Tumor Patients Discharged from Hospital
(2) Ages for Tumor Patients Discharged from Hospital
4.3 Research on Mortality of Residents Suffering from Tumor Disease
4.3.1 Research on Mortality of Top 10 Malignant Tumors
(1) Research on Overall Mortality of Top 10 Malignant Tumors
(2) Research on Mortality of Top 10 Malignant Tumors by Sex
(3) Research on Mortality of Top 10 Malignant Tumors by Region (Urban or Rural)
4.3.2 Research on Mortality of Urban Residents Suffering from Tumor Disease
4.3.3 Research on Mortality of Rural Residents Suffering from Tumor Disease
4.4 Market Status of Tumor Medical Service
4.4.1 Status of Tumor Medical Resources
(1) Total General Hospitals and Tumor Special Hospitals
(2) Beds in Tumor Departments in Hospital
4.4.2 Tumor Medical Service Status
(1) Emergency Visits in Tumor Departments of Medical Institution
(2) Total Discharged Patients in Tumor Departments of Medical Institution
Chapter 5: Analysis of Different Types of Tumor Hospitals
5.1 Analysis of Malignant Lung Tumor Market
5.1.1 Incidence Rate of Malignant Lung Tumor
5.1.2 Mortality of Malignant Lung Tumor
5.1.3 Recovery Rate of Malignant Lung Tumor
5.1.4 Medical Service Demand for Malignant Lung Tumor
(1) Treatment Technology for Malignant Lung Tumor
(2) Total Malignant Lung Tumor Patients Discharged from Hospital
(3) Medical Expense for Malignant Lung Tumor
5.1.5 Drug Demand for Malignant Lung Tumor
(1) Drug Catalogue for Malignant Lung Tumor
(2) Medical Expense for Malignant Lung Tumor
5.2 Analysis of Malignant Stomach Tumor Market
5.2.1 Incidence Rate of Malignant Stomach Tumor
5.2.2 Mortality of Malignant Stomach Tumor
5.2.3 Recovery Rate of Malignant Stomach Tumor
5.2.4 Medical Service Demand for Malignant Stomach Tumor
(1) Treatment Technology for Malignant Stomach Tumor
(2) Total Malignant Stomach Tumor Patients Discharged from Hospital
(3) Medical Expense for Malignant Stomach Tumor
5.2.5 Drug Demand for Malignant Stomach Tumor
(1) Drug Catalogue for Malignant Stomach Tumor
(2) Medical Expense for Malignant Stomach Tumor
5.3 Analysis of Malignant Liver Tumor Market
5.3.1 Incidence Rate of Malignant Liver Tumor
5.3.2 Mortality of Malignant Liver Tumor
5.3.3 Recovery Rate of Malignant Liver Tumor
5.3.4 Treatment Technology for Malignant Liver Tumor
5.3.5 Drug Catalogue for Malignant Liver Tumor
5.3.6 Medical Expense for Malignant Liver Tumor
5.4 Analysis of Malignant Breast Tumor Market
5.4.1 Incidence Rate of Malignant Breast Tumor
5.4.2 Mortality of Malignant Breast Tumor
5.4.3 Recovery Rate of Malignant Breast Tumor
5.4.4 Treatment Technology for Malignant Breast Tumor
5.4.5 Drug Catalogue for Malignant Breast Tumor
5.4.6 Medical Expense for Malignant Breast Tumor
5.5 Analysis of Malignant Bladder Tumor Market
5.5.1 Incidence Rate of Malignant Bladder Tumor
5.5.2 Mortality of Malignant Bladder Tumor
5.5.3 Recovery Rate of Malignant Bladder Tumor
5.5.4 Medical Service Demand for Malignant Bladder Tumor
(1) Treatment Technology for Malignant Bladder Tumor
(2) Total Malignant Bladder Tumor Patients Discharged from Hospital
(3) Medical Expense for Malignant Bladder Tumor
5.5.5 Drug Demand for Curing Malignant Bladder Tumor
(1) Drug Catalogue for Malignant Bladder Tumor
(2) Medical Expense for Malignant Bladder Tumor
5.6 Analysis of Malignant Esophagus Tumor Market
5.6.1 Incidence Rate of Malignant Esophagus Tumor
5.6.2 Mortality of Malignant Esophagus Tumor
5.6.3 Recovery Rate of Malignant Esophagus Tumor
5.6.4 Medical Service Demand for Malignant Esophagus Tumor
(1) Treatment Technology for Malignant Esophagus Tumor
(2) Total Malignant Esophagus Tumor Patients Discharged from Hospital
(3) Medical Expense for Malignant Esophagus Tumor
5.6.5 Drug Demand for Curing Malignant Esophagus Tumor
(1) Drug Catalogue for Malignant Esophagus Tumor
(2) Medical Expense for Malignant Esophagus Tumor
5.7 Analysis of Malignant Cervix Tumor Market
5.7.1 Incidence Rate of Malignant Cervix Tumor
5.7.2 Mortality of Malignant Cervix Tumor
5.7.3 Recovery Rate of Malignant Cervix Tumor
5.7.4 Medical Service Demand for Malignant Cervix Tumor
(1) Treatment Technology for Malignant Cervix Tumor
(2) Total Malignant Cervix Tumor Patients Discharged from Hospital
(3) Medical Expense for Malignant Cervix Tumor
5.7.5 Drug Demand for Curing Malignant Cervix Tumor
(1) Drug Catalogue for Malignant Cervix Tumor
(2) Medical Expense for Malignant Cervix Tumor
Chapter 6: Case Study of Operation of Anti-tumor Drug Enterprises
6.1 Case Study of Multinational Anti-tumor Drug Enterprises
6.1.1 Roche
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.2 Novartis
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.3 Bayer
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.4 Merck
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.5 Pfizer
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.6 AstraZeneca
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.7 Glaxosmithkline
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.8 Amgen
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.9 Bristol-Myers Squibb
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.10 Eli Lilly
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.1.11 Sanofi Aventis
(1) Development Overview
(2) R&D Situation of Anti-tumor Drugs
(3) Production Situation of Anti-tumor Drugs
(4) Market Pattern of Anti-tumor Drugs
6.2 Case Study of Domestic Anti-tumor Drug Enterprises
6.2.1 Jiangsu Hengrui Medicine Co., Ltd.
(1) Development Overview
(2) Organization Structure
(3) Operation Situation
1) Major Economic Indicators
2) Profitability
3) Operation Capability
4) Debt-paying Ability
5) Development Capability
(4) Market Position of Anti-tumor Drugs
(5) Market Distribution of Anti-tumor Drugs
(6) R&D Strength of Anti-tumor Drugs
(7) Types of Anti-tumor Drugs in the Course of Study
(8) Operational Strengths and Weaknesses
(9) Latest Development Trend
6.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd.
(1) Development Overview
(2) Operation Situation
1) Major Economic Indicators
2) Profitability
Under the circumstances of environmental pollution, deepening of aging degree, and increasing working and living pressure, there are more and more patients suffering from tumor diseases in China, which stimulates the fast development of tumor drugs market.
Under the circumstances of environmental pollution, deepening of aging degree, and increasing working and living pressure, there are more and more patients suffering from tumor diseases in China, which stimulates the fast development of tumor drugs market. With such background, the domestic excellent anti-tumor drugs manufacturers pay more attention to the industry market research, especially to the in-depth researches on the industry development environment and customer demand trend changes. Because of this, a large number of excellent anti-tumor drug brands rise up rapidly, and gradually become leading corporations in anti-tumor drug industry!
With Forward’s long-term tracking and collecting market data of anti-tumor drug industry, we roundly and accurately analyze the industry structure system for you from the view of mastering the whole industry. On the basis of analyzing the scale of anti-tumor drug industry, this report mainly focuses on firstly analyzing the development scale, competitive landscape of China anti-tumor drug industry and its markets of major anti-tumor drugs. Next, it conducts research on the prevalence rate, consultation rate and mortality of patients suffering from tumor disease. On this basis, it performs an analysis on overall tumor medical service market and major demand for tumor medical market. Then it analyzes some domestic anti-tumor drug enterprises, from the perspectives of operation status, market position of anti-tumor drugs, R&D capability, and researchable products, etc. At last, it forecasts the development prospects for industry based on its development driving factors and development trend, moreover, it analyzes the investment status, investment strategy and risk tips for the industry.
The most distinctive characteristics of this report is forward-looking and timeliness. Based on future development tracks and years’ practice experience of anti-tumor drug industry, we conduct prudent analysis and forecast for anti-tumor drug industry’s future development trend. This report helps anti-tumor drug manufacturers, R&D institutions, marketing enterprises and investment enterprises to precisely grasp current latest developments of the industry.
This report will help anti-tumor drug manufacturers, R&D institutions, marketing enterprises and investment enterprises precisely grasp the latest development trend, and find the blank, opportunity, growth, profit spots and others in the market of industry in advance, and grasp the market demand and trends that has not been found in the perspective of forward-looking. It also helps form a sustainable development advantage, effectively avoid investment risks in the industry, effectively consolidate or extend according strategic target markets, and firmly hold the initiative right to compete.
Here, we would like to express our sincere gratitude to Ministry of Public Health, Ministry of State Information Center, Bureau of Statistics of China, China Customs, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report!
Notice: All the market data, especially corporations’ ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!
Special tips: Ignoring some subtle hints in the violent change of external environment, and failure of updating strategic decisions timely will finally lead to the loss of competitive advantage. A true successful company will make scientific researches on external environment consciously or unconsciously, so as to formulate a key scientific operating strategy!
Best wishes for every enterprise with a big dream that can draw up a high-quality operating decision, to effectively avoid the risks and continuously gain the success.
Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Anti-tumor Drug Industry
The National Bureau of Statistics Foreign-related investigation Permission
National Innovation Company and Dual Software Certified Enterprise
The only DRC desginated Enterprise of the Industry Yearbook
National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation
Guangdong Province Enterprise of Observing Contract and Valuing Credit
Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.
Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.
Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.
Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.
Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.
Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.
Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.
Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.
Free Hotline：+86 400-068-7188
Customer Hotline：+86 755 - 82925195 / 82925295
Email Address：service@qianzhan.com
3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China
Location：Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China
Quality Assured
Offer a forward-looking vision to all of our customers.
Customer Service
We welcome any feedbacks and suggestions to make our customers 100% satisfied.
Qualification Certificates
Having more than 20 qualification certificates, including Innovation Company Certificate and Foreign-related investigation Permission etc.
Customers Testimonials
Thank you for recognizing our high quality products and professional, rigorous and sincere service.
